Other variants include energy-boosting, melatonin and slimming patches, reflecting a broader shift toward functional, lifestyle-driven products
Patients should be educated on the signs of misuse and the importance of adhering to prescribed dosages to mitigate risks
Summary: Retatrutide and tesamorelin are both peptide-based compounds used in metabolic medicine, but retatrutide is an unapproved triple incretin receptor agonist in clinical trials, while tesamorelin is a GHRH analogue licensed in the US for HIV-associated lipodystrophy but unlicensed in the UK
(Hims & Hers, NYSE: HIMS), the leading health and wellness platform, today released new data showing that its personalized, digital-first approach to weight loss is driving meaningful, sustainable results, laying the groundwork for lasting success
Thank you for your positive feedback
Cagrilintide is currently not available as a purchasable product at BergdorfBio and is treated exclusively as a research substance
